Abstract: A titanium silicalite molecular sieve has a micropore specific surface area of 320-500 m2/g, a micropore volume of 0.1-0.4 cm3/g, a mesopore specific surface area of 50-100 m2/g, a mesopore volume of 0.075-0.1 cm3/g, and a particle size of 100-250 nm. Its micropore specific surface area accounts for 50-90% of the total specific surface area. A catalyst contains the titanium silicalite molecular sieve carrier and is loaded with nano-gold particles. The catalyst has a micropore volume of 0.06-0.4 cm3/g and a particle size of 100-250 nm. The catalyst is prepared by subjecting the titanium silicalite molecular sieve to an alkaline treatment with an aqueous aliphatic amine solution and then loading same with nano-gold particles. The catalyst is used for an olefin epoxidation reaction, a cycloolefin epoxidation reaction, a phenol hydroxylation reaction, and a cyclohexanone ammoximation reaction.

Abstract: The present application discloses a terminal structure for conduction cooling high temperature superconducting cable, comprising: a cable terminal body; a terminal thermal insulation shell, in which a vacuum thermal insulation cavity is formed, and the cable terminal body being arranged in the vacuum thermal insulation cavity; a refrigeration mechanism comprising a refrigeration output part extending into the vacuum thermal insulation cavity, and the refrigeration output part being connected to the cable terminal body through a cooling-conducting structure.

Abstract: The present application discloses a terminal structure for conduction cooling high temperature superconducting cable, comprising: a cable terminal body; a terminal thermal insulation shell, in which a vacuum thermal insulation cavity is formed, and the cable terminal body being arranged in the vacuum thermal insulation cavity; a refrigeration mechanism comprising a refrigeration output part extending into the vacuum thermal insulation cavity, and the refrigeration output part being connected to the cable terminal body through a cooling-conducting structure.

Abstract: A composition of herbal medicine which can be used for shrimp disease treatment, includes the following ingredients: Lobelia chinensis Lour, Folium Loropetali, composition X and fishmeal, crude protein, soymeal, powder, dextrin, glucose and minerals. The composition is used in manufacturing three different medicaments and for the different medicaments, the composition X includes one or more ingredients of astragalus, vitexin flower, elephantopus flower and Coptis chinensis leaf. The composition and the medicaments are effective in treating the shrimp infectious disease, protozoa and improving the shrimp immune system.